2025 - 2025

FUROSCIX®

Continued FUROSCIX Growth

  • Chronic Kidney Disease indication FDA approved on March 6, 2025

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.

scPharmaceuticals is now part of MannKind. We’re excited about this new chapter and what it means for our team, partners, and patients.